Correlagen competitive assessment 3 23-09

•Download as PPT, PDF•

1 like•395 views

This document provides a competitive assessment of Correlagen Diagnostics and other genetic testing companies. It summarizes their offerings across various disease areas including cardiology, autism, immunology and ophthalmology. It also evaluates their commercialization capabilities, genetic testing processes, and resources. The document analyzes each company's test menu, proprietary intellectual property, branding, customer relationships, pricing, promotional resources, testing capabilities, quality and costs. It also reviews their financial performance and leadership teams.

Technology Education

Correlagen Diagnostics

Competitive Assessment

March 23, 2009

Competitive Assessment
• Offerings (Cardiology, Autism, Immunology, Opthalmology)
– Test menu
– Test groupings
– Proprietary IP
• Commercialization Capabilities
– Branding / positioning
– Customer relationships
– Pricing
– Promotional resources
– Service effectiveness
• Gene Testing Process
– Testing capabilities
– Testing quality
– Testing Cost
• Resources
– Financials
– Leadership team

Offerings: Cardiology
CDx GeneDx PGx Partners Celera
• HCM Current
• DCM • Coronary heart
Test Menu • disease

(diseases) Pipeline
• KiF-6 – CAD risk
assessment
• LPA –stroke & MI
risk assessment
• Stroke
• Deep vein
thrombosis

Test
Panels

Proprietar
y IP

Offerings: Autism
CDx GeneDx Athena Others?
• PTEN

Test Menu
(diseases)

Test
Panels

Proprietar
y IP

Offerings: Immunology
CDx GeneDx Progene XDx
•

Test Menu
(diseases)

Test
Panels

Proprietar
y IP

Offerings: Opthalmology
CDx- ArticDx Retinoblast Other?
Optherion oma
• • MaculaRisk for
AMD
Test Menu
(diseases)

Test
Panels

Proprietar
y IP

Commercialization Capabilities
CDx GeneDx PGx Partners Celera
Branding / • “Genetics lab run
Positioning by geneticists”
• Outstanding
science; superior
educational &
clinical support;
affordability
Customer • Focus on • Focus on
Relationships 2,000-2,500 cardiologists
geneticists

Pricing

Promotional • Salesforce began • Salesforce
Resources mid-’08, now x reps of ~20 reps

• TAT of x • TAT of x
Service

Gene Testing Process
CDx GeneDx PGx Partners Celera
• • DNA sequencing
• Gene chip on
Testing high resolution
constitutional array
Capabilities oligonucleotide
platform
• Claim to do high-
throughput
sequencing

Testing
“Quality”

Cost
Position

Resources
CDx GeneDx PGx Partners Celera Other?
• Acquired by
BRL for $17m
Financial 10/06
• GeneDx
Revenues
$5.4 (CY’06),
$9.9 (FY’07),
$17-18(FY’08)
• EBITDA
>30%

• NIH
Geneticists
Leadership

This guide is developed to provide a structured approach for conducting a high quality competitive analysis. It provides a detailed approach and methodology for competitor assessment in five key topic areas: - business/portolio overview - management and people - product/service and technology - cost structure and operations - marketing and sales The competitor and information analysis is divided into several steps: - develop internal cost model and capability baseline - conduct competitor data collection and synthesis - evaluate size and nature of competitive differences - assess potential competitor strategies and implications Each steps contain detail description of activities, examples, and tools used. The document also includes an interview guide for the user to jump-start the process. gazhoo.com

How to Anticipate and Outmaneuver Your Rivals: A Case Study of Achieving Adva...IntelCollab.com

Developing High-Impact Communication Forms to Brief Senior Leaders: Optimizin...

Best Practices

Competitive Assessments and Clinical Landscape Assessments are crucial to the success of new products in the pharmaceutical industry. In order to inform busy executives quickly and effectively, market intelligence and analytics leaders must develop briefing templates that are clear, concise, and impactful. This study identifies winning strategies for effectively informing senior leaders through Competitive Landscape Summaries and Clinical Development Profile Maps. The research will help executives to understand what the important elements to include are, and what are the best formats for two critical healthcare briefing templates: : 1) the Competitive Landscape Summary Map and 2) the Development Landscape Profile Map (often described as the Data Disclosure or Clinical Trials Progress Summary). Read more at: http://www.best-in-class.com/bestp/domrep.nsf/products/developing-high-impact-communication-forms-to-brief-senior-leaders-optimizing-competitive-assessment-data-disclosure-summaries?OpenDocument

TalentGuider - Capability Development in Pharma functions

Markus Moravek

Business Excellence: Making Change Management "Value-Add"

wtgevents

Beyond Gamification: 7 Core Concepts for Creating Compelling Products Amy Jo Kim

SWOT FOR COMPETITIVE ASSESSMENTGaphor Panimbang

Most organizations today are facing an increasingly competitive global market, requiring greater brand and product differentiation than ever before. In this environment, assessment of competitor content offerings provides valuable insights that can be leveraged when creating near- and long-term content strategies. Whether highlighting opportunities for creating new content, repositioning current offerings or completely overhauling content, competitive assessment enables content strategists to provide specific, targeted recommendations that can transform a brand and win the hearts and minds of consumers.

Neo4j Demo: Using Knowledge Graphs to Classify Diabetes Patients (GlaxoSmithK...

Neo4j

Driving Innovation through Licensing Competitive Intelligence and Big Data…

Paragon Solutions

To see the demo, download it here: http://www.consultparagon.com/webinar-driving-innovation-through-licensing-competitive-intelligence-and-big-data-analytics.html Today’s pharmaceutical companies are in a competitive brawl to rapidly identify, value and license promising drug candidates from external sources. This requires a significant investment in time and money, with no guarantee of success. To identify product opportunities ahead of a competitor requires a unique blend of competitive intelligence, advanced search and qualification technology, and the ability to quickly and accurately value a potential investment. In this session, you will learn how to maximize the investment in time spent searching, qualifying and valuing new assets. This approach offers competitive advantage by putting key information used to decide whether to accelerate, abandon or hold on an opportunity at licensing and acquisitions executives’ fingertips.

27-09-2012 ModiQuest (Jos Raats)

Radboud universitair medisch centrum

Slas2012 Whoeck

Wolfgang G. Hoeck

Diagnosly day oneStanford University

Accelerate Your Discovery with QIAGEN Service Solutions for Biomarker Researc...

QIAGEN

This slidedeck will highlight QIAGEN’s service capabilities in sample isolation, microarray and NGS-sequencing, qPCR panel and custom assay development and bioinformatics as we look at the identification of potential biomarkers and gene signatures. The applications of QIAGEN Service Core in microRNA discovery for toxicology markers in serum and plasma and in identification of RNA signatures for tumor stratification are featured. Learn how you can accelerate your research with QIAGEN service solutions.

05 longo addf-2.14.12plmiami

Enhance Genomic Research with Polygenic Risk Score Calculations in SVS

Golden Helix

Golden Helix’s SNP & Variation Suite (SVS) has been used by researchers around the world to do trait analysis and association testing on large cohorts of samples in both humans and other species. The latest SVS release introduces a significant leap in capabilities, with a focus on advanced Polygenic Risk Score (PRS) calculations. PRS has become a fundamental tool in genomic research, enabling the identification of correlations between genotypic variants and phenotypes across large populations. This enhancement is particularly relevant for researchers working on large cohorts and meta-analysis. Please join us as we explore: -SVS Workflow Review: A review of the extensive capabilities of SVS to meaningful insights from large cohorts and association test result datasets -Computing Polygenic Risk Scores: An overview of the PRS capabilities in SVS, including Clumping and Thresholding and creation of multiple PRS models -Evaluating and Applying PRS: Evaluating PRS models in-sample and out-of-sample and applying PRS models to perform trait prediction -Future Implications: Brief exploration of how these advancements in SVS could influence future genomic research. This webcast will explore how SVS facilitates the creation of multiple PRS models from large-scale genomic data, such as those obtained from extensive cohort studies or comprehensive meta-analyses. Join us to discover how these latest updates in SVS are supporting large-scale genomic research.

Integrating Laboratory Services

Medpace

28 the ams solution ann hoffman - vitalea

CPSA-2012_5-Minutes-Fame

Can scan final 2012 berkeleyStanford University

Processing Hereditary Cancer Panels in VarSeq

Golden Helix

Processing variants related to cancer is an incredibly critical process and a primary goal is to not only assess the variants rapidly but also accurately. A major improvement to cancer panel workflow efficiency is to utilize VarSeq for variant filtering, annotating, and interpretation. In this webcast we’ll cover some important quality assurance capabilities VarSeq provides, multiple approaches to build targeted panels, how to access/utilize numerous cancer annotations, and finally work through the ACMG guideline process on the selected germline cancer variants. The overall goal is to cover the basics of building the cancer gene panel project template so that it can be used routinely in high throughput environments.

Viewers also liked

Business Plan Training Session 5 Management

cbehn1

Business Plan Training Session 3: Competition

cbehn1

Business Plan Training Session 2: Opportunity Assessment

cbehn1

Business Plan Training Session 1: Defining the Business

cbehn1

StoryPulse TOI Competitive Assessment

FOCALCXM

Connecting The Dots: Which pharma companies are succeeding in the social medi...

Ogilvy Health

Porter’S Five Force Model In Pharma Industries

Pradeep555

Environmental Scanning:complete concept.

Ashutosh Mishra

Ersnt & Young Pharma 3.0 Business Model Zaki Sellam

Generating Insights: Using Competitive Assessment to Shape Your Content Strategy

Laura Blaydon

Viewers also liked (10)

Business Plan Training Session 5 Management

Business Plan Training Session 3: Competition

Business Plan Training Session 2: Opportunity Assessment

Business Plan Training Session 1: Defining the Business

StoryPulse TOI Competitive Assessment

Connecting The Dots: Which pharma companies are succeeding in the social medi...

Porter’S Five Force Model In Pharma Industries

Environmental Scanning:complete concept.

Ersnt & Young Pharma 3.0 Business Model

Generating Insights: Using Competitive Assessment to Shape Your Content Strategy

Similar to Correlagen competitive assessment 3 23-09

Neo4j Demo: Using Knowledge Graphs to Classify Diabetes Patients (GlaxoSmithK...

Neo4j

Driving Innovation through Licensing Competitive Intelligence and Big Data…

Paragon Solutions

27-09-2012 ModiQuest (Jos Raats)

Radboud universitair medisch centrum

Slas2012 Whoeck

Wolfgang G. Hoeck

Diagnosly day oneStanford University

Accelerate Your Discovery with QIAGEN Service Solutions for Biomarker Researc...

QIAGEN

05 longo addf-2.14.12plmiami

Enhance Genomic Research with Polygenic Risk Score Calculations in SVS

Golden Helix

Integrating Laboratory Services

Medpace

28 the ams solution ann hoffman - vitalea

CPSA-2012_5-Minutes-Fame

Can scan final 2012 berkeleyStanford University

Processing Hereditary Cancer Panels in VarSeq

Golden Helix

Angela Osborne Presentation - Personalised Healthcare Revolution

Bath & Bristol Enterprise Network

Large Scale PCA Analysis in SVS

Golden Helix

Golden Helix’s SNP & Variation Suite (SVS) has been used by researchers around the world to do association testing and trait analysis on large cohorts of samples in both humans and other species. As samples size increase to do population-scale genomics, the analysis methods need to adapt to remain computable on your analysis workstation. One of the most popular methods for determining population structure in SVS is Principal Component Analysis. In this webcast, we review the fundamentals of this methodology, as well as how we have advanced the state of the art by implementing a new “Large Data PCA” capability in SVS, handling over 10 times as many samples as previously possible at a fraction of the time. Join us as we cover: A review of SVS association testing and trait analysis capabilities Usage of Principle Component Analysis to discern population structure Scaling PCA beyond the limitations of computer hardware Other SVS improvements based on ongoing feedback from the user community SVS continues to move forward as a flexible and powerful tool to perform genotype and Large-N variant analysis. We hope you enjoy this webcast highlighting the exciting new features and select enhancements we have made.

MedITEX IVF Product PresentationMedITEX - Medical IT Experts

Introducing VSClinical: Streamlining ACMG Variant Interpretation Guidelines

Golden Helix

We have seen the widespread adoption of VarSeq in the clinic. It is chosen for its versatility and flexibility as well as the extensive catalog of annotations provided by Golden Helix. In a genetic testing scenario, VarSeq provides the annotated and filtered list of high-quality variants to that are ready for the user to classify and interpret. In this webcast, we introduce a new product VSClinical that enables the interpretation of variants following the ACMG Guidelines. By incorporating new algorithms and annotation sources, detailed variant scoring and classification can occur right within VarSeq and without the need for additional external tools or resources. Join us to see these upcoming capabilities: Streamline the ACMG scoring guidelines with supportive recommendation and incorporated historical precedence See the new algorithms behind the automated recommendation algorithm, and how they provide various levels of evidence Drill down to an unprecedented level of supporting evidence for mutation hot spots, splice site predictions, and related clinical assertions Build your own lab practices around new capabilities of blinded interpretations, collaborative interpretation review and detailed audit logs for CLIA compliance Finalize your interpretation for a sample and compose the clinical report with the classified variants and their interpretation In combination, this can be a game-changer for any clinical lab looking to improve their efficiency and reproducibility of the most complex step in the genetic testing workflow.

VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis

Golden Helix

In the rapidly evolving field of genomic analysis, staying current with the latest research, data sources, and test advancements is crucial. In this webinar, we review how VarSeq addresses the needs to stay on top of the latest with the release of VarSeq 2.6.0. This release features an exome-optimized workflow for LOH and CNV calling as well as the introduction of VSPGx to produce pharmacogenomic reports for gene panels as well as exomes and genomes. With the recent release of gnomAD v4, we have had many requests for the integration of this large update to the most population frequency source. With VarSeq 2.6.0, the latest version of gnomAD has been integrated into VSClinical and the updated tracks spans beyond variants to cover CNVs and gene scores to update all your workflows to the latest data. In this webcast, we will cover. Improved VS-CNV performance and updated exome analysis workflows. Pharmacogenomics in action: Utilizing VSPGx for exome and genome assessments. gnomAD v4 in practice: Updated automated and manual variant interpretation workflows. Join us for an insightful session on the latest VarSeq 2.6.0 features, bringing you the most up-to-date data and workflows for your genomic analysis.

DCN Company Profile 2015Brendan O'Farrell

BICR & Subjective Endpoints - Increasing Precision and Accuracy in Your Clin...

JennyOShea

For many of today’s trials, the primary endpoint is a subjective assessment and depends on physician-rated or even patient-reported data, which means validation to the FDA and other regulatory agencies is automatically more difficult. For registration trials with subjective endpoints, blinded independent central review (BICR) of the trial data – including both images and other data such as laboratory and pathology data, autopsy reports, and physical descriptions – can be extremely valuable and may be executed through an endpoint assessment committee (EAC).

Next-generation genomics: an integrative approachHong ChangBum

Similar to Correlagen competitive assessment 3 23-09 (20)

Neo4j Demo: Using Knowledge Graphs to Classify Diabetes Patients (GlaxoSmithK...

Driving Innovation through Licensing Competitive Intelligence and Big Data…

27-09-2012 ModiQuest (Jos Raats)

Slas2012 Whoeck

Diagnosly day one

Accelerate Your Discovery with QIAGEN Service Solutions for Biomarker Researc...

05 longo addf-2.14.12

Enhance Genomic Research with Polygenic Risk Score Calculations in SVS

Integrating Laboratory Services

28 the ams solution ann hoffman - vitalea

Can scan final 2012 berkeley

Processing Hereditary Cancer Panels in VarSeq

Angela Osborne Presentation - Personalised Healthcare Revolution

Large Scale PCA Analysis in SVS

MedITEX IVF Product Presentation

Introducing VSClinical: Streamlining ACMG Variant Interpretation Guidelines

VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis

DCN Company Profile 2015

BICR & Subjective Endpoints - Increasing Precision and Accuracy in Your Clin...

Next-generation genomics: an integrative approach

Recently uploaded

UiPath Test Automation using UiPath Test Suite series, part 4

DianaGray10

Welcome to UiPath Test Automation using UiPath Test Suite series part 4. In this session, we will cover Test Manager overview along with SAP heatmap. The UiPath Test Manager overview with SAP heatmap webinar offers a concise yet comprehensive exploration of the role of a Test Manager within SAP environments, coupled with the utilization of heatmaps for effective testing strategies. Participants will gain insights into the responsibilities, challenges, and best practices associated with test management in SAP projects. Additionally, the webinar delves into the significance of heatmaps as a visual aid for identifying testing priorities, areas of risk, and resource allocation within SAP landscapes. Through this session, attendees can expect to enhance their understanding of test management principles while learning practical approaches to optimize testing processes in SAP environments using heatmap visualization techniques What will you get from this session? 1. Insights into SAP testing best practices 2. Heatmap utilization for testing 3. Optimization of testing processes 4. Demo Topics covered: Execution from the test manager Orchestrator execution result Defect reporting SAP heatmap example with demo Speaker: Deepak Rai, Automation Practice Lead, Boundaryless Group and UiPath MVP

Essentials of Automations: The Art of Triggers and Actions in FME

Safe Software

In this second installment of our Essentials of Automations webinar series, we’ll explore the landscape of triggers and actions, guiding you through the nuances of authoring and adapting workspaces for seamless automations. Gain an understanding of the full spectrum of triggers and actions available in FME, empowering you to enhance your workspaces for efficient automation. We’ll kick things off by showcasing the most commonly used event-based triggers, introducing you to various automation workflows like manual triggers, schedules, directory watchers, and more. Plus, see how these elements play out in real scenarios. Whether you’re tweaking your current setup or building from the ground up, this session will arm you with the tools and insights needed to transform your FME usage into a powerhouse of productivity. Join us to discover effective strategies that simplify complex processes, enhancing your productivity and transforming your data management practices with FME. Let’s turn complexity into clarity and make your workspaces work wonders!

20240607 QFM018 Elixir Reading List May 2024

Matthew Sinclair

Why You Should Replace Windows 11 with Nitrux Linux 3.5.0 for enhanced perfor...

SOFTTECHHUB

The choice of an operating system plays a pivotal role in shaping our computing experience. For decades, Microsoft's Windows has dominated the market, offering a familiar and widely adopted platform for personal and professional use. However, as technological advancements continue to push the boundaries of innovation, alternative operating systems have emerged, challenging the status quo and offering users a fresh perspective on computing. One such alternative that has garnered significant attention and acclaim is Nitrux Linux 3.5.0, a sleek, powerful, and user-friendly Linux distribution that promises to redefine the way we interact with our devices. With its focus on performance, security, and customization, Nitrux Linux presents a compelling case for those seeking to break free from the constraints of proprietary software and embrace the freedom and flexibility of open-source computing.

Communications Mining Series - Zero to Hero - Session 1

DianaGray10

This session provides introduction to UiPath Communication Mining, importance and platform overview. You will acquire a good understand of the phases in Communication Mining as we go over the platform with you. Topics covered: • Communication Mining Overview • Why is it important? • How can it help today’s business and the benefits • Phases in Communication Mining • Demo on Platform overview • Q/A

Alt. GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using ...

James Anderson

Effective Application Security in Software Delivery lifecycle using Deployment Firewall and DBOM The modern software delivery process (or the CI/CD process) includes many tools, distributed teams, open-source code, and cloud platforms. Constant focus on speed to release software to market, along with the traditional slow and manual security checks has caused gaps in continuous security as an important piece in the software supply chain. Today organizations feel more susceptible to external and internal cyber threats due to the vast attack surface in their applications supply chain and the lack of end-to-end governance and risk management. The software team must secure its software delivery process to avoid vulnerability and security breaches. This needs to be achieved with existing tool chains and without extensive rework of the delivery processes. This talk will present strategies and techniques for providing visibility into the true risk of the existing vulnerabilities, preventing the introduction of security issues in the software, resolving vulnerabilities in production environments quickly, and capturing the deployment bill of materials (DBOM). Speakers: Bob Boule Robert Boule is a technology enthusiast with PASSION for technology and making things work along with a knack for helping others understand how things work. He comes with around 20 years of solution engineering experience in application security, software continuous delivery, and SaaS platforms. He is known for his dynamic presentations in CI/CD and application security integrated in software delivery lifecycle. Gopinath Rebala Gopinath Rebala is the CTO of OpsMx, where he has overall responsibility for the machine learning and data processing architectures for Secure Software Delivery. Gopi also has a strong connection with our customers, leading design and architecture for strategic implementations. Gopi is a frequent speaker and well-known leader in continuous delivery and integrating security into software delivery.

By Design, not by Accident - Agile Venture Bolzano 2024

Pierluigi Pugliese

GraphSummit Singapore | Enhancing Changi Airport Group's Passenger Experience...

Neo4j

Dr. Sean Tan, Head of Data Science, Changi Airport Group Discover how Changi Airport Group (CAG) leverages graph technologies and generative AI to revolutionize their search capabilities. This session delves into the unique search needs of CAG’s diverse passengers and customers, showcasing how graph data structures enhance the accuracy and relevance of AI-generated search results, mitigating the risk of “hallucinations” and improving the overall customer journey.

State of ICS and IoT Cyber Threat Landscape Report 2024 preview

Prayukth K V

The IoT and OT threat landscape report has been prepared by the Threat Research Team at Sectrio using data from Sectrio, cyber threat intelligence farming facilities spread across over 85 cities around the world. In addition, Sectrio also runs AI-based advanced threat and payload engagement facilities that serve as sinks to attract and engage sophisticated threat actors, and newer malware including new variants and latent threats that are at an earlier stage of development. The latest edition of the OT/ICS and IoT security Threat Landscape Report 2024 also covers: State of global ICS asset and network exposure Sectoral targets and attacks as well as the cost of ransom Global APT activity, AI usage, actor and tactic profiles, and implications Rise in volumes of AI-powered cyberattacks Major cyber events in 2024 Malware and malicious payload trends Cyberattack types and targets Vulnerability exploit attempts on CVEs Attacks on counties – USA Expansion of bot farms – how, where, and why In-depth analysis of the cyber threat landscape across North America, South America, Europe, APAC, and the Middle East Why are attacks on smart factories rising? Cyber risk predictions Axis of attacks – Europe Systemic attacks in the Middle East Download the full report from here: https://sectrio.com/resources/ot-threat-landscape-reports/sectrio-releases-ot-ics-and-iot-security-threat-landscape-report-2024/

Observability Concepts EVERY Developer Should Know -- DeveloperWeek Europe.pdf

Paige Cruz

Monitoring and observability aren’t traditionally found in software curriculums and many of us cobble this knowledge together from whatever vendor or ecosystem we were first introduced to and whatever is a part of your current company’s observability stack. While the dev and ops silo continues to crumble….many organizations still relegate monitoring & observability as the purview of ops, infra and SRE teams. This is a mistake - achieving a highly observable system requires collaboration up and down the stack. I, a former op, would like to extend an invitation to all application developers to join the observability party will share these foundational concepts to build on:

FIDO Alliance Osaka Seminar: Overview.pdf

FIDO Alliance

The Art of the Pitch: WordPress Relationships and Sales

Laura Byrne

Clients don’t know what they don’t know. What web solutions are right for them? How does WordPress come into the picture? How do you make sure you understand scope and timeline? What do you do if sometime changes? All these questions and more will be explored as we talk about matching clients’ needs with what your agency offers without pulling teeth or pulling your hair out. Practical tips, and strategies for successful relationship building that leads to closing the deal.

Secstrike : Reverse Engineering & Pwnable tools for CTF.pptx

nkrafacyberclub

Climate Impact of Software Testing at Nordic Testing Days

Kari Kakkonen

My slides at Nordic Testing Days 6.6.2024 Climate impact / sustainability of software testing discussed on the talk. ICT and testing must carry their part of global responsibility to help with the climat warming. We can minimize the carbon footprint but we can also have a carbon handprint, a positive impact on the climate. Quality characteristics can be added with sustainability, and then measured continuously. Test environments can be used less, and in smaller scale and on demand. Test techniques can be used in optimizing or minimizing number of tests. Test automation can be used to speed up testing.

GraphSummit Singapore | Graphing Success: Revolutionising Organisational Stru...

Neo4j

Sudheer Mechineni, Head of Application Frameworks, Standard Chartered Bank Discover how Standard Chartered Bank harnessed the power of Neo4j to transform complex data access challenges into a dynamic, scalable graph database solution. This keynote will cover their journey from initial adoption to deploying a fully automated, enterprise-grade causal cluster, highlighting key strategies for modelling organisational changes and ensuring robust disaster recovery. Learn how these innovations have not only enhanced Standard Chartered Bank’s data infrastructure but also positioned them as pioneers in the banking sector’s adoption of graph technology.

Securing your Kubernetes cluster_ a step-by-step guide to success !

KatiaHIMEUR1

Today, after several years of existence, an extremely active community and an ultra-dynamic ecosystem, Kubernetes has established itself as the de facto standard in container orchestration. Thanks to a wide range of managed services, it has never been so easy to set up a ready-to-use Kubernetes cluster. However, this ease of use means that the subject of security in Kubernetes is often left for later, or even neglected. This exposes companies to significant risks. In this talk, I'll show you step-by-step how to secure your Kubernetes cluster for greater peace of mind and reliability.

Microsoft - Power Platform_G.Aspiotis.pdf

Uni Systems S.M.S.A.

PHP Frameworks: I want to break free (IPC Berlin 2024)

Ralf Eggert

In this presentation, we examine the challenges and limitations of relying too heavily on PHP frameworks in web development. We discuss the history of PHP and its frameworks to understand how this dependence has evolved. The focus will be on providing concrete tips and strategies to reduce reliance on these frameworks, based on real-world examples and practical considerations. The goal is to equip developers with the skills and knowledge to create more flexible and future-proof web applications. We'll explore the importance of maintaining autonomy in a rapidly changing tech landscape and how to make informed decisions in PHP development. This talk is aimed at encouraging a more independent approach to using PHP frameworks, moving towards a more flexible and future-proof approach to PHP development.

FIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdf

FIDO Alliance

Video Streaming: Then, Now, and in the Future

Alpen-Adria-Universität

In his public lecture, Christian Timmerer provides insights into the fascinating history of video streaming, starting from its humble beginnings before YouTube to the groundbreaking technologies that now dominate platforms like Netflix and ORF ON. Timmerer also presents provocative contributions of his own that have significantly influenced the industry. He concludes by looking at future challenges and invites the audience to join in a discussion.

Recently uploaded (20)

UiPath Test Automation using UiPath Test Suite series, part 4

Essentials of Automations: The Art of Triggers and Actions in FME

20240607 QFM018 Elixir Reading List May 2024

Why You Should Replace Windows 11 with Nitrux Linux 3.5.0 for enhanced perfor...

Communications Mining Series - Zero to Hero - Session 1

Alt. GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using ...

By Design, not by Accident - Agile Venture Bolzano 2024

GraphSummit Singapore | Enhancing Changi Airport Group's Passenger Experience...

State of ICS and IoT Cyber Threat Landscape Report 2024 preview

Observability Concepts EVERY Developer Should Know -- DeveloperWeek Europe.pdf

FIDO Alliance Osaka Seminar: Overview.pdf

The Art of the Pitch: WordPress Relationships and Sales

Secstrike : Reverse Engineering & Pwnable tools for CTF.pptx

Climate Impact of Software Testing at Nordic Testing Days

GraphSummit Singapore | Graphing Success: Revolutionising Organisational Stru...

Securing your Kubernetes cluster_ a step-by-step guide to success !

Microsoft - Power Platform_G.Aspiotis.pdf

PHP Frameworks: I want to break free (IPC Berlin 2024)

FIDO Alliance Osaka Seminar: Passkeys and the Road Ahead.pdf

Video Streaming: Then, Now, and in the Future

Correlagen competitive assessment 3 23-09

1. Correlagen Diagnostics Competitive Assessment March 23, 2009

2. Competitive Assessment • Offerings (Cardiology, Autism, Immunology, Opthalmology) – Test menu – Test groupings – Proprietary IP • Commercialization Capabilities – Branding / positioning – Customer relationships – Pricing – Promotional resources – Service effectiveness • Gene Testing Process – Testing capabilities – Testing quality – Testing Cost • Resources – Financials – Leadership team

3. Offerings: Cardiology CDx GeneDx PGx Partners Celera • HCM Current • DCM • Coronary heart Test Menu • disease (diseases) Pipeline • KiF-6 – CAD risk assessment • LPA –stroke & MI risk assessment • Stroke • Deep vein thrombosis Test Panels Proprietar y IP

4. Offerings: Autism CDx GeneDx Athena Others? • PTEN Test Menu (diseases) Test Panels Proprietar y IP

5. Offerings: Immunology CDx GeneDx Progene XDx • Test Menu (diseases) Test Panels Proprietar y IP

6. Offerings: Opthalmology CDx- ArticDx Retinoblast Other? Optherion oma • • MaculaRisk for AMD Test Menu (diseases) Test Panels Proprietar y IP

7. Commercialization Capabilities CDx GeneDx PGx Partners Celera Branding / • “Genetics lab run Positioning by geneticists” • Outstanding science; superior educational & clinical support; affordability Customer • Focus on • Focus on Relationships 2,000-2,500 cardiologists geneticists Pricing Promotional • Salesforce began • Salesforce Resources mid-’08, now x reps of ~20 reps • TAT of x • TAT of x Service

8. Gene Testing Process CDx GeneDx PGx Partners Celera • • DNA sequencing • Gene chip on Testing high resolution constitutional array Capabilities oligonucleotide platform • Claim to do high- throughput sequencing Testing “Quality” Cost Position

9. Resources CDx GeneDx PGx Partners Celera Other? • Acquired by BRL for $17m Financial 10/06 • GeneDx Revenues $5.4 (CY’06), $9.9 (FY’07), $17-18(FY’08) • EBITDA >30% • NIH Geneticists Leadership

Correlagen competitive assessment 3 23-09

Recommended

Recommended

More Related Content

Viewers also liked

Viewers also liked (10)

Similar to Correlagen competitive assessment 3 23-09

Similar to Correlagen competitive assessment 3 23-09 (20)

Recently uploaded

Recently uploaded (20)

Correlagen competitive assessment 3 23-09

Editor's Notes